Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Effects of FK-419, a GPIIb/IIIa antagonist, in a model of ischemic brain injury

Feb. 17, 2005

Thrombopoietin receptor (TPOR) activators disclosed by Nissan Chemical

Feb. 16, 2005

Update on the efficacy of rhThrombin in the management of surgery-associated bleeding

Feb. 15, 2005

New anticoagulant agents reported by Bristol-Myers Squibb

Feb. 14, 2005

Novel anticoagulant agents discovered at Lilly

Feb. 11, 2005

Arixtra receives new approval in Europe

Feb. 10, 2005

Portola begins phase Ib trial for oral anticoagulant

Feb. 9, 2005

Preclinical data on dual thromboxane synthase inhibitor and thromboxane receptor antagonist

Feb. 8, 2005

Pfizer inlicenses Schering's ADP receptor antagonist program

Feb. 4, 2005

Low recurrence of ulcer bleeding found with an aspirin plus esomeprazole regimen

Jan. 28, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...